(Q38444030)

3 September 2017

E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast (English)

1 reference

3 September 2017

1 reference

5

Irene L Andrulis

1 reference

3 September 2017

Teresa L Mastracci

1

1 reference

3 September 2017

Suzanna Tjan

series ordinal

2

1 reference

3 September 2017

Anita L Bane

series ordinal

3

1 reference

3 September 2017

Frances P O'Malley

series ordinal

4

1 reference

3 September 2017

1 June 2005

1 reference

3 September 2017

1 reference

3 September 2017

18

1 reference

3 September 2017

6

1 reference

3 September 2017

741-751

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.3800362

3 September 2017

0 references

cites work

Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800362

Atypical lobular hyperplasia and lobular carcinoma in situ: surgical and molecular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800362

Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800362

A prospective study of benign breast disease and the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800362

Lobular neoplasia of the breast: Higher risk for subsequent invasive cancer predicted by more extensive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800362

Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800362

Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800362

E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800362

Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800362

Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800362

Loss of chromosome 16q in lobular carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800362

Lobular neoplasia (so-called lobular carcinoma in situ) of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800362

Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800362

Degenerate oligonucleotide-primed PCR: General amplification of target DNA by a single degenerate primer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800362

E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800362

E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800362

7 January 2021

Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800362

7 January 2021

Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800362

7 January 2021

Risk factors for breast cancer in women with proliferative breast disease

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800362

7 January 2021

Use of degenerate oligonucleotide primed PCR (DOP-PCR) for the genotyping of low-concentration DNA samples

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800362

7 January 2021

10.1038/MODPATHOL.3800362

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

0 references

1 reference